IL-18 is secreted at significantly higher level in the synovial fluid and serum of RA patients than in normal, where it acts as an angiogenic mediator and leukocyte chemotactic agent, mediating the inflammatory process in RA (190–193). This evidence concerns the gene IL18 and rheumatoid arthritis.